AbbVie Launches $70 Million Biologics Manufacturing Expansion in Worcester to Enhance R&D Capacity AbbVie kicks off a $70 million expansion project at its Bioresearch Center in Worcester, bolstering its biologics manufacturing and R&D efforts. This investment aims to increase U.S. production capabilities.

AbbVie Launches $70 Million Biologics Manufacturing Expansion in Worcester to Enhance R&D Capacity #United_States #Worcester #AbbVie #Biologics_Manufacturing #Bioresearch_Center